Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome (3 Star)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02738450
Recruitment Status : Active, not recruiting
First Posted : April 14, 2016
Last Update Posted : January 28, 2020
National Institute on Aging (NIA)
Alzheimer's Disease Cooperative Study (ADCS)
LuMind Research Down Syndrome Foundation
Information provided by (Responsible Party):
AC Immune SA

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : May 2020